A study reveals attrition rates in geographic atrophy patients on complement inhibitor therapies, highlighting the need for ...

Jay Chhablani, MD, explains how 3D choroidal vessel segmentation transforms ophthalmology, enhancing disease diagnosis and ...

The Food and Drug Administration has granted Fast Track designation to ATH434 for the treatment of multiple system atrophy.

Hovanesian: The first diagnosis is a good time to refer, because GA patients lose visual acuity somewhat predictably, as much ...

Boehringer Ingelheim has started a proof-of-concept trial of a drug that could offer the first oral treatment for geographic atrophy (GA), a major cause of irreversible sight loss that affects ...

Astellas has shored up the competitive profile of Izervay as a treatment for eye disorder geographic atrophy (GA), getting FDA approval for an extended treatment duration. The US regulator turned ...

Anna Landre, a college student who lives with spinal muscular atrophy, found herself fighting another battle when her insurer informed her they were reducing the number of hours they would cover ...